Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE)

NCT02970305 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

403

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Pimavanserin
DRUG: Placebo

Sponsor

ACADIA Pharmaceuticals Inc.